Showing 1 - 7 results of 7 for search 'Nicoletta Pella', query time: 0.02s Refine Results
  1. 1
    HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.

    HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment. by Marica Garziera, Ettore Bidoli, Erika Cecchin, Enrico Mini, Stefania Nobili, Sara Lonardi, Angela Buonadonna, Domenico Errante, Nicoletta Pella, Mario D'Andrea, Francesco De Marchi, Antonino De Paoli, Chiara Zanusso, Elena De Mattia, Renato Tassi, Giuseppe Toffoli

    Published 2015-01-01
    Get full text
    Article
  2. 2
    A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

    A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy by Elena De Mattia, Eva Dreussi, Marcella Montico, Sara Gagno, Chiara Zanusso, Luca Quartuccio, Salvatore De Vita, Michela Guardascione, Angela Buonadonna, Mario D’Andrea, Nicoletta Pella, Adolfo Favaretto, Enrico Mini, Stefania Nobili, Loredana Romanato, Erika Cecchin, Giuseppe Toffoli

    Published 2018-10-01
    Get full text
    Article
  3. 3
    The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer

    The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer by Camilla Lisanti, Debora Basile, Silvio Ken Garattini, Annamaria Parnofiello, Carla Corvaja, Francesco Cortiula, Elisa Bertoli, Elena Ongaro, Luisa Foltran, Mariaelena Casagrande, Paola Di Nardo, Giovanni Gerardo Cardellino, Gianpiero Fasola, Angela Buonadonna, Nicoletta Pella, Giuseppe Aprile, Fabio Puglisi

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies

    Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies by Valentina Fanotto, Daniele Rossini, Mariaelena Casagrande, Francesca Bergamo, Andrea Spagnoletti, Daniele Santini, Carlotta Antoniotti, Samanta Cupini, Francesca Daniel, Vincenzo Nasca, Guglielmo Vetere, Alberto Zaniboni, Beatrice Borelli, Martina Carullo, Veronica Conca, Alessandro Passardi, Emiliano Tamburini, Gianluca Masi, Nicoletta Pella, Chiara Cremolini

    Published 2023-11-01
    Get full text
    Article
  5. 5
    Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer

    Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer by Silvio Ken Garattini, Debora Basile, Marta Bonotto, Elena Ongaro, Luca Porcu, Carla Corvaja, Monica Cattaneo, Victoria Josephine Andreotti, Camilla Lisanti, Elisa Bertoli, Giacomo Pelizzari, Donatella Iacono, Gianmaria Miolo, Giovanni Gerardo Cardellino, Angela Buonadonna, Giuseppe Aprile, Gianpiero Fasola, Fabio Puglisi, Nicoletta Pella

    Published 2021-07-01
    Get full text
    Article
  6. 6
    From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy

    From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy by Riccardo Giampieri, Pina Ziranu, Bruno Daniele, Antonio Zizzi, Daris Ferrari, Sara Lonardi, Alberto Zaniboni, Luigi Cavanna, Gerardo Rosati, Mariaelena Casagrande, Nicoletta Pella, Laura Demurtas, Maria Giulia Zampino, Pietro Sozzi, Valeria Pusceddu, Domenico Germano, Eleonora Lai, Vittorina Zagonel, Carla Codecà, Michela Libertini, Marco Puzzoni, Roberto Labianca, Stefano Cascinu, Mario Scartozzi

    Published 2020-05-01
    Get full text
    Article
  7. 7
    Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a analysis from the adjuvant TOSCA trial

    Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a analysis from the adjuvant TOSCA trial by Sandro Barni, Gerardo Rosati, Sara Lonardi, Nicoletta Pella, Maria Banzi, Maria G. Zampino, Katia F. Dotti, Lorenza Rimassa, Paolo Marchetti, Evaristo Maiello, Fabrizio Artioli, Daris Ferrari, Roberto Labianca, Paolo Bidoli, Alberto Zaniboni, Alberto Sobrero, Vincenzo Iaffaioli, Sabino De Placido, Gian Luca Frassineti, Andrea Ciarlo, Angela Buonadonna, Nicola Silvestris, Elena Piazza, Lorenzo Pavesi, Mauro Moroni, Mario Clerico, Massimo Aglietta, Paolo Giordani, Francesca Galli, Fabio Galli, Fausto Petrelli

    Published 2020-01-01
    Get full text
    Article

Search Tools: